... has submitted a new drug application (NDA) to the US Food and Drug Administration for Silenor (doxepin hydrochloride) for the treatment of insomnia. ...
... reports or the FDA's findings of safety and efficacy for other formulations of doxepin hydrochloride that have previously been approved by the FDA. ...
... has submitted a new drug application (NDA) to the US Food and Drug Administration for Silenor (doxepin hydrochloride) for the treatment of insomnia. ...
... has submitted a new drug application (NDA) to the US Food and Drug Administration for Silenor (doxepin hydrochloride) for the treatment of insomnia. ...
... Inc. (SOMX) said that it has submitted a New Drug Application or NDA to the FDA for Silenor or doxepin hydrochloride for the treatment of insomnia. ...
Somaxon Pharmaceuticals, Inc. (SOMX) has submitted a New Drug Application (NDA) to the FDA for SILENOR(TM) (doxepin hydrochloride). ...
... today announced that it has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for SILENOR(TM) (doxepin hydrochloride). ...
... PR Charts ) said that it has submitted a New Drug Application or NDA to the FDA for Silenor or doxepin hydrochloride for the treatment of insomnia. ...
... for SILENOR for the treatment of Insomnia Co announces it has submitted a New Drug Application to the FDA for SILENOR (doxepin hydrochloride). ...
... Inc. (SOMX) said that it has submitted a New Drug Application or NDA to the FDA for Silenor or doxepin hydrochloride for the treatment of insomnia. ...